Abstract | BACKGROUND: METHODS: Charge-based lipoprotein subfractions were characterized by capillary isotachophoresis (cITP). cITP analysis was performed using plasma that had been prestained with a lipophilic dye on a Beckman P/ACE MDQ system. RESULTS: Treatment with atorvastatin for 4 weeks markedly decreased the slow (s)-migrating TRL subfraction and both fast- and slow-migrating low-density lipoprotein ( LDL) subfractions, but did not affect the fast (f)-migrating TRL subfraction in this patient. ApoA-I/POPC discs consisted of two major charge-based subfractions that had the mobility of cITP fTRL and sTRL. Incubation of plasma from this patient in the presence of apoA-I/POPC discs caused not only a reduction in cITP fast- and intermediate-migrating HDL and an increase in cITP sHDL but also a reduction in fTRL and sTRL and an increase in sLDL. CONCLUSION:
|
Authors | Bo Zhang, Ritsuko Katafuchi, Hiroaki Arishima, Akira Matsunaga, Kerry-Anne Rye, Keijiro Saku |
Journal | Clinica chimica acta; international journal of clinical chemistry
(Clin Chim Acta)
Vol. 373
Issue 1-2
Pg. 55-61
(Nov 2006)
ISSN: 0009-8981 [Print] Netherlands |
PMID | 16806136
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoprotein A-I
- Apolipoprotein E2
- Heptanoic Acids
- Lipoproteins
- Macromolecular Substances
- Phosphatidylcholines
- Pyrroles
- Triglycerides
- Atorvastatin
|
Topics |
- Adult
- Apolipoprotein A-I
(chemistry, pharmacology)
- Apolipoprotein E2
(genetics)
- Atorvastatin
- Electrophoresis, Capillary
(methods)
- Heptanoic Acids
(administration & dosage, pharmacology)
- Humans
- Hyperlipoproteinemia Type III
(blood, drug therapy, genetics)
- Lipoproteins
(blood, chemistry, drug effects)
- Macromolecular Substances
(chemistry, pharmacology)
- Male
- Phenotype
- Phosphatidylcholines
(chemistry, pharmacology)
- Pyrroles
(administration & dosage, pharmacology)
- Sensitivity and Specificity
- Time Factors
- Triglycerides
(analysis)
|